SkyCell, a global leader in pharmaceutical supply chain technology, has unveiled a new AI-powered pharma monitoring solution designed to provide real-time visibility and proactive risk management for temperature-sensitive pharmaceutical shipments.
Key Features:
- Predictive Analytics: Uses AI to identify and mitigate risks before they impact product integrity.
- Hybrid Smart Logger: Functions as both a data logger and a real-time gateway, eliminating reliance on post-delivery loggers.
- Continuous Monitoring: Offers live tracking of temperature and location data across the entire supply chain.
- Seamless Integration: Syncs with enterprise platforms to remove workflow inefficiencies and data silos.
“This solution ensures pharma companies can intervene proactively—no more spreadsheets or delayed data,” said Richard Ettl, CEO and co-founder of SkyCell. “It’s about safeguarding every shipment and ensuring medicines reach patients intact.”
Industry Impact:
- Addresses the industry-wide issue of 1 in 5 temperature-sensitive shipments being compromised due to delayed monitoring.
- Supports over five million monitored shipments annually.
- Reduces dependency on disposable data loggers, improving sustainability and real-time decision-making.
Enhanced Visibility Through Microsoft Partnership:
SkyCell has also partnered with Microsoft to integrate its AI assistant, K.AI, into Microsoft Teams and Copilot, allowing users to access shipment insights, receive alerts, and collaborate—all within the Microsoft environment.